Australian biotech market watch 01/07/09
01 July, 2009 by Tim DeanCochlear, Ramsay, ResMed, Biota, Ansell
Improving medical device development
01 July, 2009 by Staff WritersNew model aims to streamline medical device development and aid in gaining regulatory approval.
Australian biotech market watch 26/06/09
26 June, 2009 by Tim DeanResMed, CSL, Biota, Sonic Healthcare, ChemGenex, Sirtex
Bionomics commences clinical trial
25 June, 2009 by Tim DeanAnti-anxiety drug, BNC210, to undergo phase I clinical trial in Adelaide.
Phosphagenics signs agreement with CSL
22 June, 2009 by Staff WritersCSL to evaluate Phosphagenics' TMP technology with the possibility of an expanded collaboration in the future.
Genome of potential bacterial factory sequenced
19 June, 2009 by Staff WritersScientists sequence genome of the N2-fixing, soil-living bacterium Azotobacter vinelandii.
Clinuvel awarded orphan drug status by EU
18 June, 2009 by Staff WritersEuropean Medicines Agency grants Clinuvel new orphan drug designation for afamelanotide.
Australian biotech market watch 12/06/09
12 June, 2009 by Staff WritersCOH, PXS, HGN, CXS, CXD, BTA
Clonal reproduction closer than ever
09 June, 2009 by Staff WritersNew technique could make cloning crops possible
Australian biotech market watch 01/06/09
01 June, 2009 by Staff WritersCSL, Probiotec, Sonic Healthcare, Flurotechnics, CathRx
Accelerated menopause could control pests
28 May, 2009 by Staff WritersScientists speed up menopause, causing infertility in crop-destroying pests. Non-surgical spaying of pets may be next step.
